# Eliquis Regulatory Post Marketing Surveillance

> **NCT01885598** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 3335 (actual)

## Conditions studied

- NonValvular Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT01885598
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-10
- **Primary completion:** 2017-09-29
- **Final completion:** 2017-09-29
- **Target enrollment:** 3335 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01885598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01885598, "Eliquis Regulatory Post Marketing Surveillance". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01885598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*